Every year, the editorial team at Challenges, one of France’s leading business magazines, selects 100 of the most promising French startups. 

We’re proud to be part of this year’s selection. This recognition reflects the strength of our mission: transforming precision oncology through genomic data analysis, ensuring every cancer patient gets the right diagnosis and the right treatment, faster.

Calyseed Capital Cell Yes invest Plateau de Saclay Business Angels Bpifrance Région Île-de-France Paris Saclay Cancer Cluster (PSCC)